Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Long-term Depression01:05

Long-term Depression

33.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.3K
Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Pilot and Numeric Relaying01:21

Pilot and Numeric Relaying

492
Pilot relaying is a type of differential protection used in power systems. It compares electrical quantities at the terminals of equipment via a communication channel instead of direct relay interconnection. This method is essential for transmission lines where the terminals are far apart, typically up to 80 km for lines with 69 to 115 kV ratings. Four types of communication channels are used for pilot relaying:
492
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.2K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.2K
Depressants01:28

Depressants

437
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
437

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utah Quality Advancement Laboratory Scholars: A Mentorship Program to Support Research and Dissemination in Clinical Track Hospitalist Faculty.

Journal of Brown hospital medicine·2026
Same author

The use of memantine for prevention of Alzheimer's disease: Pilot feasibility study rationale and protocol.

Contemporary clinical trials communications·2026
Same author

Electronic Clinical Quality Measures of Antibiotic Use in Hospitalized Adults with Uncomplicated Community-acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Visuomotor adaptation and savings are preserved in individuals with depression.

Journal of motor learning and development·2026
Same author

Increased Aperiodic Exponents Track Depression Symptom Severity.

bioRxiv : the preprint server for biology·2026
Same author

Adult-child interaction emotional image set: Subject ratings of childhood sexual abuse survivors.

Child abuse & neglect·2026

Related Experiment Video

Updated: Feb 4, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Propofol for Treatment-Resistant Depression: A Pilot Study.

Brian J Mickey1,2,3, Andrea T White1,2, Anna M Arp1

  • 1Department of Psychiatry, University Neuropsychiatric Institute, University of Utah, Salt Lake City, UT.

The International Journal of Neuropsychopharmacology
|September 28, 2018
PubMed
Summary
This summary is machine-generated.

Propofol anesthesia shows promise for treating resistant depression, demonstrating significant antidepressant effects with good tolerability. This approach may offer a rapid and durable alternative to existing therapies.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 12, 2010

40.6K

Related Experiment Videos

Last Updated: Feb 4, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 12, 2010

40.6K

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Psychiatry

Background:

  • Propofol, a general anesthetic, interacts with NMDA and GABA receptors.
  • Treatment-resistant depression (TRD) remains a significant clinical challenge.
  • The potential antidepressant properties of propofol are under investigation.

Purpose of the Study:

  • To assess the feasibility and tolerability of deep propofol anesthesia for TRD.
  • To gather preliminary data on the efficacy of propofol in treating depression.
  • To compare propofol's effects with electroconvulsive therapy (ECT) in self-rated depression scores.

Main Methods:

  • An open-label trial involving 10 participants with moderate-to-severe TRD.
  • Each participant received 10 propofol infusions targeting electroencephalographic suppression.
  • The Hamilton Depression Rating Scale (HDRS) was the primary outcome measure.

Main Results:

  • Propofol infusions were well-tolerated with no serious adverse events.
  • Mean HDRS scores decreased by 20 points (58% improvement from baseline).
  • Six out of 10 participants achieved a clinical response, with sustained effects in most responders.

Conclusions:

  • High-dose propofol is feasible and well-tolerated in patients with TRD.
  • Propofol may induce rapid and durable antidepressant effects, potentially with fewer side effects than ECT.
  • Further controlled studies are needed to confirm efficacy and elucidate mechanisms of action.